News
2h
Stocktwits on MSNSoFi Stock Plunges After-Hours On $1.5B Offering — Retail Feels Only An Acquisition ‘Makes Sense’
SoFi Technologies (SOFI) stock slipped 6.6% in extended trading on Tuesday after the fintech firm launched a public offering of $1.5 billion worth of common stock after posting strong second-quarter ...
8h
Investor's Business Daily on MSNCommvault Stock Surges On Strong Quarter. CFO Says 'Cyber Resilience' Demand Strong.
Commvault stock gained after the cloud-based data backup and security software company reported fiscal Q1 results.
As previously reported, William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform after the company reported Q2 results and cut ...
11h
TipRanks on MSNNeoGenomics downgraded to Market Perform from Outperform at William Blair
William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, ...
14h
Stocktwits on MSNSoFi’s ‘Disruptive’ Bank Model Gets A Wall Street Thumbs Up: Retail Chatter Explodes 380% In 24 Hours
SoFi Technologies Inc. (SOFI) received a bullish endorsement from William Blair on Tuesday, following its second-quarter (Q2) ...
Sarepta Therapeutics shares jumped over 36% on Tuesday after the company said it had received FDA approval to restart ...
1d
Barchart on MSNTesla Just Signed a Chip Supply Deal with Samsung. What Does That Mean for TSLA Stock?
Tesla (TSLA) shares closed higher today after the company announced one of its largest tech partnerships ever with Samsung Electronics. The agreement worth an estimated $16.5 billion will see the ...
William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.
1don MSN
William Blair's Dorsheimer: Tesla investors want to see Musk innovate, Samsung deal supports that
Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...
In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...
Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...
Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results